Efficacy and safety of selective serotonin reuptake inhibitors on cardiovascular outcomes of patients with post-acute coronary syndrome depression: a systematic review and meta-analysis
Event: ESC Congress 2025
Topic: Pharmacotherapy
Session: Pharmacotherapy in coronary artery disease (2)
